PNS209 IMPACT OF GENERICS AND BIOSIMILARS ON BRANDED DRUG LISTING DECISIONS IN SINGAPORE
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2109
https://www.valueinhealthjournal.com/article/S1098-3015(19)34487-0/fulltext
Title :
PNS209 IMPACT OF GENERICS AND BIOSIMILARS ON BRANDED DRUG LISTING DECISIONS IN SINGAPORE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34487-0&doi=10.1016/j.jval.2019.09.2109
First page :
Section Title :
Open access? :
No
Section Order :
11827